Cytokinetics
Daniel Jacoby is an experienced medical professional currently serving as Executive Medical Director of Clinical Research at Cytokinetics since January 2022. Prior to this role, Daniel held the position of Clinical Director of Innovation at Yale New Haven Health from April 2021 to January 2022. Additionally, Daniel was an Associate Professor of Medicine at the Yale School of Medicine from July 2009 to January 2022, where responsibilities included directing the Cardiomyopathy Program and the Yale Heart Failure program. Daniel's educational background includes a Bachelor's degree in Judaic Studies from Yale University, a Doctor of Medicine degree from Yale School of Medicine, and advanced training through a Chief Resident position and a Cardiology Fellowship at Mount Sinai School of Medicine and Columbia Presbyterian Hospital respectively.
Cytokinetics
15 followers
Cytokinetics, Inc. is a publicly traded biopharmaceutical company based in South San Francisco, California, that develops muscle activators as potential treatments for people with diseases characterized by impaired or declining muscle function.